Sunday, November 1, 2026

Sherwin And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Sherwin And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

2. Sherwin

10% sales growth and 52.5% return on equity

The Sherwin-Williams Company develops, manufactures, distributes, and sells paints, coatings, and related products to professional, industrial, commercial, and retail customers.

Sherwin's sales growth this year is expected to be 6.1% and 4.5% for next year.

Year-on-year quarterly revenue growth grew by 9.1%, now sitting on 18.36B for the twelve trailing months.

Sherwin's sales growth for the next quarter is 10%. The company's growth estimates for the present quarter and the next is 20.6% and 11.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 52.5%.

Volatility

Sherwin's last day, last week, and last month's current volatility was 0.93%, 0.66%, and 1.12%, respectively.

Sherwin's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.08% (day), 1.22% (last week), and 1.95% (last month), respectively.

Sherwin's Stock Yearly Top and Bottom Value

Sherwin's stock is valued at $257.27 at 11:22 EST, below its 52-week high of $257.72 and way above its 52-week low of $154.01.

Sherwin's Moving Average

Sherwin's value is above its 50-day moving average of $236.75 and above its 200-day moving average of $237.38.

3. Catalent, Inc.

20.2% sales growth and 11.27% return on equity

Catalent, Inc., together with its subsidiaries, provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide.

Catalent, Inc.'s sales growth this year is expected to be 25.6% and 9.7% for next year.

Year-on-year quarterly revenue growth grew by 26.3%, now sitting on 3.46B for the twelve trailing months.

Catalent, Inc.'s sales growth for the next quarter is 20.2%. The company's growth estimates for the ongoing quarter and the next is 46% and 12.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.27%.

Volatility

Catalent, Inc.'s last day, last week, and last month's current volatility was 1.71%, 1.14%, and 1.75%, respectively.

Catalent, Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.13% (day), 1.86% (last week), and 2.83% (last month), respectively.

Catalent, Inc.'s Stock Yearly Top and Bottom Value

Catalent, Inc.'s stock is valued at $109.56 at 11:22 EST, way below its 52-week high of $127.68 and way higher than its 52-week low of $52.41.

Catalent, Inc.'s Moving Average

Catalent, Inc.'s worth is higher than its 50-day moving average of $108.60 and above its 200-day moving average of $102.74.

4. Signature Bank

16.8% sales growth and 10% return on equity

Signature Bank commercial banking products and services.

Signature Bank's sales growth this year is expected to be 20.1% and 12.7% for next year.

Year-on-year quarterly revenue growth grew by 11.3%, now sitting on 1.35B for the twelve trailing months.

Signature Bank's sales growth for the next quarter is 16.8%. The company's growth estimates for the current quarter and the next is 51.6% and 33.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10%.

Volatility

Signature Bank's last day, last week, and last month's current volatility was 0.17%, 0.90%, and 1.84%, respectively.

Signature Bank's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.80% (day), 2.16% (last week), and 3.79% (last month), respectively.

Signature Bank's Stock Yearly Top and Bottom Value

Signature Bank's stock is valued at $227.54 at 11:22 EST, below its 52-week high of $249.94 and way above its 52-week low of $71.44.

Signature Bank's Moving Average

Signature Bank's worth is above its 50-day moving average of $226.60 and way higher than its 200-day moving average of $153.29.

5. Churchill Downs

296.6% sales growth and 3.03% return on equity

Churchill Downs Incorporated operates as a racing, online wagering, and gaming entertainment company in the United States.

Churchill Downs's sales growth this year is expected to be 42% and 19.4% for next year.

Year-on-year quarterly revenue growth declined by 0.9%, now sitting on 1.05B for the twelve trailing months.

Churchill Downs's sales growth for the next quarter is 296.6%. The company's growth estimates for the ongoing quarter and the next is 1020% and 569.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.03%.

Volatility

Churchill Downs's last day, last week, and last month's current volatility was 0.03%, 1.27%, and 1.93%, respectively.

Churchill Downs's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.40% (day), 3.11% (last week), and 3.52% (last month), respectively.

Churchill Downs's Stock Yearly Top and Bottom Value

Churchill Downs's stock is valued at $217.35 at 11:22 EST, way under its 52-week high of $258.32 and way higher than its 52-week low of $85.24.

Churchill Downs's Moving Average

Churchill Downs's worth is below its 50-day moving average of $233.41 and higher than its 200-day moving average of $200.99.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com
Sherwin And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity | Via News